application

Ehave, Inc. Issues CEO Letter to Stockholders, Studies on Substantial Development and Outlook for 2021

MIAMI, Dec. 17, 2020 (World NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader of electronic therapeutics offering evidence-centered therapeutic interventions to sufferers, announces that Ben Kaplan, President, Main Government Officer and Chairman, has issued a letter to Ehave’s stockholders. The complete textual content is as follows:

To My Fellow Stockholders,

About the course of 2020, Ehave, Inc. has produced substantial development in advancing our strategic plan and strike several milestones in our journey. From a company standpoint, we are a thoroughly reporting company with the SEC. We have utilized for OTCQB registration and anticipate filing with the Canadian Securities Exchange by the conclude of the yr. The combined endeavours of our administration staff, Board of Directors, and healthcare advisory board has resulted in numerous achievements which includes the adhering to highlights:

Ehave expanded its psychedelic psychological wellness system to far better provide researchers and clinicians, even though

Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical Trials – Press Release

CAMBRIDGE, Mass.–(Business Wire)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune and blood systems reset via stem cell transplant to more patients, today highlighted progress across its stem cell mobilization and collection and targeted conditioning programs, and set expectations for 2021. These updates will be discussed during a webcast presentation at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14 at 7:50 a.m. PST / 10:50 a.m. EST.

“I’m exceptionally proud of the entire Magenta team who continued to adapt and execute across our portfolio, despite the disruptions that characterized 2020. This past year, we continued to drive our vision to bring immune and blood systems reset to more patients. We announced four pipeline-expanding partnerships, presented clinical and pre-clinical data across our pipeline and secured the capital that we expect can fund our operations into 2023. We continue

Bintai Kinden’s lover Generex files trademark software for li-Key vaccine



a close up of a bottle: Bintai Kinden Corp Bhd's partner Generex Biotechnology Corp has filed for a trademark for its li-Key vaccine and patent for its Ii-Key-SARS-CoV-2 vaccine. NSTP/HASRIYASYAH SABUDIN


© Presented by New Straits Times
Bintai Kinden Corp Bhd’s spouse Generex Biotechnology Corp has submitted for a trademark for its li-Key vaccine and patent for its Ii-Key-SARS-CoV-2 vaccine. NSTP/HASRIYASYAH SABUDIN

KUALA LUMPUR: Bintai Kinden Corp Bhd’s husband or wife Generex Biotechnology Corp has submitted for a trademark for its li-Important vaccine and patent for its Ii-Important-SARS-CoV-2 vaccine.

Developed as a ‘complete vaccine’ the Ii-Vital vaccine know-how presents the safest and very best route for fast development of Covid-19 vaccine that can be safely and securely administered to all people, which include adolescents, kids and expecting gals with out worry of immune relevant facet outcomes.

Bintai Kinden reported the vaccine is developed to regulate the immune technique to supply a qualified, neutralising antibody reaction with out generating off-target, non-neutralising antibodies that can guide to antibody dependent enhancement of illness.

On the development and development of Generex’s Covid-19 vaccine, Bintai Kinden

NuScale and UAMPS agreements progress options for SMR plant : New Nuclear

12 January 2021

Agreements introduced yesterday in between NuScale Ability and Utah Related Municipal Energy Units (UAMPS) to aid the progress of a undertaking to deploy compact modular reactors (SMRs) at the Idaho Countrywide Laboratory (INL) could lead to the placement of a first purchase for NuScale Energy Modules in 2022.

How a NuScale plant could possibly glance (Image: NuScale)

NuScale Chairman and CEO John Hopkins reported: “This is the 1st move in a prudent deployment program.”

The Carbon Cost-free Energy Project (CFPP) will be a 720 MWe NuScale electricity plant, comprising up to 12 NuScale Power Modules, to be situated at the US Office of Energy’s (DOE) INL web site. The newest orders are the result of lately signed agreements to regulate and de-possibility the venture. They include things like the Progress Charge Reimbursement Settlement concerning UAMPS and NuScale, and the USD1.355 billion multi-12 months Financial Assistance Award from

Development Software program (PRGS) Set to Announce Earnings on Thursday


Development Program (NASDAQ:PRGS) is scheduled to be releasing its earnings info right after the sector closes on Thursday, January 14th. Analysts hope Progress Application to publish earnings of $.67 for each share for the quarter. Folks that want to register for the company’s earnings meeting phone can do so applying this url.

Shares of PRGS stock opened at $47.16 on Thursday. Progress Software program has a 52-7 days lower of $28.09 and a 52-7 days superior of $52.50. The stock has a sector cap of $2.13 billion, a selling price-to-earnings ratio of 37.73 and a beta of 1.02. The organization has a debt-to-equity ratio of .74, a fast ratio of 1.41 and a present ratio of 1.41. The business has a fifty working day moving common of $42.11 and a 200-working day shifting typical of $38.42.

In relevant news, SVP Gary Quinn marketed 7,116 shares of the inventory in

Escalating Software of Apheresis Treatments to Develop A number of

Apheresis Sector

Current shift from solitary dose to double dose apheresis is indicative of the large need for apheresis strategies among the people struggling from serious ailments. Leading business players are getting calculated growth actions to develop application of the therapeutic apheresis method, which is currently applied as the very first line and supportive treatment in the treatment method of about 87 conditions, as found by the American Society for Apheresis (ASFA). Nevertheless, lack of availability of donors and fears about histocompatibility could make damaging sentiments between people, inadvertently impeding revenue prospective of the apheresis industry to a certain extent. Defying all odds however, the apheresis current market is projected to progress at an amazing CAGR of ~10% all through the forecast interval (2020 – 2025), as noted by Truth.MR in its most recent analyze on the marketplace.

Request a report sample to get complete current market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4352

Ultragenyx Announces Progress Across Broad Gene Therapy Portfolio and Positive Longer-Term Data from Multiple Phase 1/2 Gene Therapy Studies

Durable and Clinically Meaningful Responses Reported from Phase 1/2 Studies of DTX401 for GSDIa and DTX301 for OTC

Phase 3 Studies for DTX401 and DTX301 to Begin in 2021

IND for UX701 for Wilson Disease Submitted; Expect to Enter Clinic in First Half 2021 using AAV Drug Product Made by HeLa PCL Platform

NOVATO, Calif. , Jan. 08, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, today announced positive longer-term safety and efficacy data from the first three cohorts of the ongoing Phase 1/2 studies of DTX401, an investigational adeno-associated virus (AAV) gene therapy for Glycogen Storage Disease Type Ia (GSDIa), and DTX301, an AAV gene therapy for ornithine transcarbamylase (OTC) deficiency. In addition, dosing is nearing completion for the prophylactic steroid cohorts in both studies. Discussions with regulatory agencies continue to

Minimal progress in law enforcement probe, no arrests or cost sheet as a result considerably

Considering the fact that then even so, the probe appears to have fizzled out. Even though the subsequent February clashes in Delhi amid the CAA protests experienced been additional to the investigation, there has not been a lot headway. On January 10 very last calendar year, the Delhi Police had produced shots of nine suspects in the JNU violence circumstance and claimed JNUSU president Aishe Ghosh was one of them. Subsequently they experienced also questioned some of the suspects.

With the COVID-19 lockdown nevertheless, issues show up to have been on a hiatus. According to an Indian Express report, when 15 suspects had been discovered by the Delhi Law enforcement Crime Department, these pupils had returned dwelling as India went underneath lockdown. Reportedly, while the SIT experienced questioned all-around 88 folks, recording statements from instructors, students, wardens, safety guards and other people abide by-up investigation remains pending. “After questioning,

Osinbajo presents Economic Sustainability Plan Progress Report to Buhari

President Buhari receives ESP report from VP Osinbajo

*VP meets NorthEast Humanitarian Hub management, pledges support for establishment of Social Innovation and Research Institute

In their first official meeting for the year 2021, President Muhammadu Buhari on Tuesday received Prof. Yemi Osinbajo, SAN in his office where the Vice President updated him on the progress recorded so far in the implementation of the Economic Sustainability Plan (ESP).

President Buhari had mandated Vice President Osinbajo as chair of the Economic Sustainability Committee, to coordinate the implementation of the ESP aimed at cushioning the economic effects of the COVID-19 pandemic.

About three months into the implementation of different components of the plan namely, MSMEs Survival Fund; Social Housing Scheme, and Solar Home System, among others, Nigerians across different sectors have been impacted.

MSMEs SURVIVAL FUND: MORE NIGERIANS RECEIVE PAYROLL SUPPORT PAYMENTS, ARTISAN & TRANSPORT GRANTS

For the Payroll Support track of the

Pamplin Media Team – West Linn-Wilsonville College District bond initiatives development

Lots of initiatives are continue to in the design and style phase and have integrated target group tests


As the calendar year commences anew, West Linn-Wilsonville School District team are going ahead with projects funded by the $206.8 million money bond, which voters authorised final November.

Addition, renovation at Wilsonville Significant Faculty

Wilsonville Superior University will have a new 600-man or woman auditorium, supplemental parking, artificial turf softball fields and electricity-successful lights upgrades. WHS improvements also include a renovation of the present-day auditorium and black box theater, classroom updates and improved basic safety and security.

A structure committee composed of community customers and district and faculty management fulfilled consistently, according to a district report, and the 1st spherical of local community emphasis groups has been done. Up coming, the bond workers prepare todo one more round of concentrate group and then entire the Conditional Use Permit software.

Design is predicted